SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001785982-21-000076
Filing Date
2021-04-09
Accepted
2021-04-09 16:01:49
Documents
71
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sf0106h_10k.htm 10-K 1104646
2 EXHIBIT 10.56 sf0106h_ex10-56.htm EX-10.56 14751
3 EXHIBIT 10.57 sf0106h_ex10-57.htm EX-10.57 42245
4 EXHIBIT 21.3 sf0106h_ex21-3.htm EX-21.3 1146
5 EXHIBIT 23.1 sf0106h_ex23-1.htm EX-23.1 3294
6 EXHIBIT 31.1 sf0106h_ex31-1.htm EX-31.1 9535
7 EXHIBIT 31.2 sf0106h_ex31-2.htm EX-31.2 9529
8 EXHIBIT 32 sf0106h_ex32.htm EX-32 5976
9 GRAPHIC img001.jpg GRAPHIC 96052
  Complete submission text file 0001785982-21-000076.txt   5897126

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE bixt-20201231.xml EX-101.INS 1122155
11 XBRL SCHEMA FILE bixt-20201231.xsd EX-101.SCH 53412
12 XBRL CALCULATION FILE bixt-20201231_cal.xml EX-101.CAL 45297
13 XBRL DEFINITION FILE bixt-20201231_def.xml EX-101.DEF 238049
14 XBRL LABEL FILE bixt-20201231_lab.xml EX-101.LAB 405178
15 XBRL PRESENTATION FILE bixt-20201231_pre.xml EX-101.PRE 325129
Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464
Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35027 | Film No.: 21817802
SIC: 2834 Pharmaceutical Preparations